Author:
Yong Jean H. E.,Beca Jaclyn,Hoch Jeffrey S.
Publisher
Springer Science and Business Media LLC
Subject
Public Health, Environmental and Occupational Health,Health Policy,Pharmacology
Reference20 articles.
1. Canadian Institute for Health Information. Drug expenditure in Canada 1985 to 2009. Ottawa: CIHI; 2010.
2. Clement FM, Harris A, Li JJ, Yong K, Lee KM, Manns BJ. Using effectiveness and cost-effectiveness to make drug coverage decisions: a comparison of Britain, Australia, and Canada. JAMA. 2009;302(13):1437–43.
3. Hill SR, Mitchell AS, Henry DA. Problems with the interpretation of pharmacoeconomic analyses: a review of submissions to the Australian Pharmaceutical Benefits Scheme. JAMA. 2000;283(16):2116–21.
4. Morgan SG, McMahon M, Mitton C, Roughead E, Kirk R, Kanavos P, et al. Centralized drug review processes in Australia, Canada, New Zealand, and the United Kingdom. Health Aff (Millwood). 2006;25(2):337–47.
5. Späth HM, Allenet B, Carrère MO. L’utilisation de l’information économique dans le secteur de la santé: le choix des médicaments à inclure dans les livrets thérapeutiques hospitaliers. J Econ Med. 2000;18(3–4):147–61.
Cited by
20 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献